Signalling from dead cells drives inflammation and vessel remodelling

Vascular Pharmacology

Volumn 56, Issue 5-6, 2012, Pages 187-192

  Bennett, Martin ^a   Yu, Haixiang ^a   Clarke, Murray ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Apoptosis; Atherosclerosis; Necrosis; Remodelling

Indexed keywords

CYTOKINE; ELASTIN; GLYCOSAMINOGLYCAN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

APOPTOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL DEATH; HUMAN; INFLAMMATION; NECROSIS; NEOINTIMA; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TISSUE REGENERATION; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE; VASCULAR SURGERY; ANIMAL; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SMOOTH MUSCLE FIBER;

ANIMALS; APOPTOSIS; ATHEROSCLEROSIS; CELL MOVEMENT; CELL PROLIFERATION; CYTOKINES; HUMANS; INFLAMMATION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHAGOCYTOSIS; SIGNAL TRANSDUCTION;

EID: 84866161679     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2012.01.006     Document Type: Review

References (85)

1. Abid M.R., Yano K., Guo S., Patel V.I., Shrikhande G., Spokes K.C., Ferran C., Aird W.C. Forkhead transcription factors inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia. J. Biol. Chem. 2005, 280:29864-29873.
2. Ait-Oufella H., Kinugawa K., Zoll J., Simon T., Boddaert J., Heeneman S., Blanc-Brude O., Barateau V., Potteaux S., Merval R., Esposito B., Teissier E., Daemen M.J., Leseche G., Boulanger C., Tedgui A., Mallat Z. Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. Circulation 2007, 115:2168-2177.
3. Ait-Oufella H., Pouresmail V., Simon T., Blanc-Brude O., Kinugawa K., Merval R., Offenstadt G., Leseche G., Cohen P.L., Tedgui A., Mallat Z. Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1429-1431.
4. Allard D., Figg N., Bennett M.R., Littlewood T.D. Akt regulates the survival of vascular smooth muscle cells via inhibition of FoxO3a and GSK3. J. Biol. Chem. 2008, 283:19739-19747.
5. Aprahamian T., Rifkin I., Bonegio R., Hugel B., Freyssinet J.M., Sato K., Castellot J.J., Walsh K. Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J. Exp. Med. 2004, 199:1121-1131.
6. Ares M.P.S., Pornares M.I., Thyberg J., Junttiberggren L., Berggren P.O., Diczfalusy U., Kallin B., Bjorkhem I., Orrenius S., Nilsson J. Ca2+ channel blockers verapamil and nifedipine inhibit apoptosis induced by 25-hydroxycholesterol in human aortic smooth muscle cells. J. Lipid Res. 1997, 38:2049-2061.
7. Bai H., Pollman M.J., Inishi Y., Gibbons G.H. Regulation of vascular smooth muscle cell apoptosis. Modulation of bad by a phosphatidylinositol 3-kinase-dependent pathway. Circ. Res. 1999, 85:229-237.
8. Bauriedel G., Hutter R., Welsch U., Bach R., Sievert H., Luderitz B. Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability. Cardiovasc. Res. 1999, 41:480-488.
9. Belanger A.J., Scaria A., Lu H., Sullivan J.A., Cheng S.H., Gregory R.J., Jiang C. Fas ligand/Fas-mediated apoptosis in human coronary artery smooth muscle cells: therapeutic implications of fratricidal mode of action. Cardiovasc. Res. 2001, 51:749-761.
10. Bennett M.R. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc. Res. 1999, 41:361-368.
11. Bennett M.R. Life and death in the atherosclerotic plaque. Curr. Opin. Lipidol. 2010, 21:422-426.
12. Bennett M.R., Boyle J.J. Apoptosis of vascular smooth muscle cells in atherosclerosis. Atherosclerosis 1998, 138:3-9.
13. Bennett M., Evan G., Schwartz S. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J. Clin. Invest. 1995, 95:2266-2274.
14. Bennett M.R., Littlewood T.D., Schwartz S.M., Weissberg P.L. Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis. Circ. Res. 1997, 81:591-599.
15. Bennett M., Macdonald K., Chan S.-W., Simari R., Luzio J., Weissberg P. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science 1998, 282:290-293.
16. Bentzon J.F., Sondergaard C.S., Kassem M., Falk E. Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice. Circulation 2007, 116:2053-2061.
17. Berceli S.A., Davies M.G., Kenagy R.D., Clowes A.W. Flow-induced neointimal regression in baboon polytetrafluoroethylene grafts is associated with decreased cell proliferation and increased apoptosis. J. Vasc. Surg. 2002, 36:1248-1255.
18. Björkerud B., Björkerud S. Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages and fibroblasts. Arterioscler. Thromb. 1996, 16:416-424.
19. Boyle J., Bowyer D., Weissberg P., Bennett M. Human blood-derived macrophages induce apoptosis in human plaque-derived vascular smooth muscle cells by Fas ligand/Fas interactions. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1402-1407.
20. Boyle J.J., Weissberg P.L., Bennett M.R. Human macrophage-induced vascular smooth muscle cell apoptosis requires NO enhancement of Fas/Fas-L interactions. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1624-1630.
21. Boyle J.J., Weissberg P.L., Bennett M.R. Tumor necrosis factor-{alpha} promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1553-1558.
22. Cho A., Courtman D., Langille L. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ. Res. 1995, 76:168-175.
23. Cho A., Mitchell L., Koopmans D., Langille B.L. Effects of changes in blood flow rate on cell death and cell proliferation in carotid arteries of immature rabbits. Circ. Res. 1997, 81:328-337.
24. Clarke M.C., Figg N., Maguire J.J., Davenport A.P., Goddard M., Littlewood T.D., Bennett M.R. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat. Med. 2006, 12:1075-1080.
25. Clarke M.C., Littlewood T.D., Figg N., Maguire J.J., Davenport A.P., Goddard M., Bennett M.R. Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration. Circ. Res. 2008, 102:1529-1538.
26. Clarke M., Talib S., Figg N., Bennett M. Vascular smooth muscle cell apoptosis induces IL-1-directed inflammation; effects of hyperlipidemia-mediated inhibition of phagocytosis. Circ. Res. 2010, 106:363-372.
27. Clowes A.W., Clowes M.M. Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin. Lab. Investig. 1985, 52:611-616.
28. Clowes A.W., Schwartz S.M. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ. Res. 1985, 56:139-145.
29. Deblois D., Tea B.S., Dam T.V., Tremblay J., Hamet P. Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats. Hypertension 1997, 29:340-349.
30. Dimmeler S., Haendeler J., Nehls M., Zeiher A.M. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1 beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J. Exp. Med. 1997, 185:601-607.
31. Dimmeler S., Assmus B., Hermann C., Haendeler J., Zeiher A.M. Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis. Circ. Res. 1998, 83:334-341.
32. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999, 399:601-605.
33. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 1998, 101:890-898.
34. Fearon W., Fearon D. Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonist. Circulation 2008, 117:2577-2579.
35. Fernandez-Hernando C., Jozsef L., Jenkins D., Di Lorenzo A., Sessa W.C. Absence of Akt1 reduces vascular smooth muscle cell migration and survival and induces features of plaque vulnerability and cardiac dysfunction during atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2009, 29:2033-2040.
36. Geng Y., Libby P. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1b converting enzyme. Am. J. Pathol. 1995, 147:251-266.
37. Geng Y., Wu Q., Muszynski M., Hansson G., Libby P. Apoptosis of vascular smooth-muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1-beta. Arterioscler. Thromb. Vasc. Biol. 1996, 16:19-27.
38. Geng Y.J., Henderson L.E., Levesque E.B., Muszynski M., Libby P. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 1997, 17:2200-2208.
39. Goncalves I., Stenstrom K., Skog G., Mattsson S., Nitulescu M., Nilsson J. Short communication: dating components of human atherosclerotic plaques. Circ. Res. 2010, 106:1174-1177.
40. Helwig J.J., Le Bouteiller P. Physiological smooth muscle cell apoptosis contributes to the uterine vascular remodeling in human early pregnancy. Circ. Res. 2007, 100:754-756.
41. Horiuchi S., Sakamoto Y., Sakai M. Scavenger receptors for oxidized and glycated proteins. Amino Acids 2003, 25:283-292.
42. Hsieh C.C., Yen M.H., Yen C.H., Lau Y.T. Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells. Cardiovasc. Res. 2001, 49:135-145.
43. Ihling C., Szombathy T., Nampoothiri K., Haendeler J., Beyersdorf F., Uhl M., Zeiher A.M., Schaefer H.E. Cystic medial degeneration of the aorta is associated with p53 accumulation, Bax upregulation, apoptotic cell death, and cell proliferation. Heart 1999, 82:286-293.
44. Imanishi T., Han D.K., Hofstra L., Hano T., Nishio I., Conrad Liles W., Gown A.M., Schwartz S.M., Gorden A.M. Apoptosis of vascular smooth muscle cells is induced by Fas ligand derived from monocytes/macrophage. Atherosclerosis 2002, 161:143-151.
45. Isner J., Kearney M., Bortman S., Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation 1995, 91:2703-2711.
46. Jawien A., Bowen-Pope D.F., Lindner V., Schwartz S.M., Clowes A.W. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J. Clin. Invest. 1992, 89:507-511.
47. Kavurma M.M., Bennett M.R. Expression, regulation and function of trail in atherosclerosis. Biochem. Pharmacol. 2008, 75:1441-1450.
48. Kavurma M.M., Figg N., Bennett M.R., Mercer J., Khachigian L.M., Littlewood T.D. Oxidative stress regulates IGF1R expression in vascular smooth-muscle cells via p53 and HDAC recruitment. Biochem. J. 2007, 207:79-87.
49. Khan M., Pelengaris S., Cooper M., Smith C., Evan G., Betteridge J. Oxidised lipoproteins may promote inflammation through the selective delay of engulfment but not binding of apoptotic cells by macrophages. Atherosclerosis 2003, 171:21-29.
50. Kiss R.S., Elliott M.R., Ma Z., Marcel Y.L., Ravichandran K.S. Apoptotic cells induce a phosphatidylserine-dependent homeostatic response from phagocytes. Curr. Biol. 2006, 16:2252-2258.
51. Kockx M.M. Apoptosis in the atherosclerotic plaque - quantitative and qualitative aspects. Arterioscler. Thromb. Vasc. Biol. 1998, 18:1519-1522.
52. Kono H., Rock K.L. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 2008, 8:279-289.
53. Kumar A., Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler. Thromb. Vasc. Biol. 1997, 17:2238-2244.
54. Langille B.L., Odonnell F. Reductions In arterial diameter produced by chronic decreases in blood-flow are endothelium-dependent. Science 1986, 231:405-407.
55. Liu G., Wang J., Park Y.J., Tsuruta Y., Lorne E.F., Zhao X., Abraham E. High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine. J. Immunol. 2008, 181:4240-4246.
56. Lutgens E., De Muinck E.D., Kitslaar P.J., Tordoir J.H., Wellens H.J., Daemen M.J. Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques. Cardiovasc. Res. 1999, 41:473-479.
57. Malik N., Francis S.E., Holt C.M., Gunn J., Thomas G.L., Shepherd L., Chamberlain J., Newman C.M.H., Cumberland D.C., Crossman D.C. Apoptosis and cell proliferation after porcine coronary angioplasty. Circulation 1998, 98:1657-1665.
58. Morimoto K., Janssen W.J., Fessler M.B., Mcphillips K.A., Borges V.M., Bowler R.P., Xiao Y.Q., Kench J.A., Henson P.M., Vandivier R.W. Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J. Immunol. 2006, 176:7657-7665.
59. Okura Y., Brink M., Zahid A.A., Anwar A., Delafontaine P. Decreased expression of insulin-like growth factor-1 and apoptosis of vascular smooth muscle cells in human atherosclerotic plaque. J. Mol. Cell. Cardiol. 2001, 33:1777-1789.
60. Patel V.A., Zhang Q.J., Siddle K., Soos M.A., Goddard M., Weissberg P.L., Bennett M.R. Defect in insulin-like growth factor-1 survival mechanism in atherosclerotic plaque-derived vascular smooth muscle cells is mediated by reduced surface binding and signaling. Circ. Res. 2001, 88:895-902.
61. Perlman H., Sata M., Krasinski K., Dorai T., Buttyan R., Walsh K. Adenovirus-encoded hammerhead ribozyme to Bcl-2 inhibits neointimal hyperplasia and induces vascular smooth muscle cell apoptosis. Cardiovasc. Res. 2000, 45:570-578.
62. Pollman M., Hall J., Gibbons G. Acute Induction of medial cell apoptosis by angioplasty Injury: regulation by redox-sensitive mechanisms. Circulation 1997, 96:I-560.
63. Pollman M., Hall J., Mann M., Gibbons G. Inhibition of neointimal cell Bcl-x expression induces apoptosis and regression of vascular disease. Nature Med. 1998, 4:222-227.
64. Proudfoot D., Skepper J.N., Hegyi L., Bennett M.R., Shanahan C.M., Weissberg P.L. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ. Res. 2000, 87:1055-1062.
65. Pryshchep S., Sato K., Goronzy J.J., Weyand C.M. T cell recognition and killing of vascular smooth muscle cells in acute coronary syndrome. Circ. Res. 2006, 98:1168-1176.
66. Sambrano G.R., Parthasarathy S., Steinberg D. Recognition of oxidatively damaged erythrocytes by a macrophage receptor with specificity for oxidized low density lipoprotein. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:3265-3269.
67. Sato K., Niessner A., Kopecky S.L., Frye R.L., Goronzy J.J., Weyand C.M. TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque. J. Exp. Med. 2006, 203:239-250.
68. Savill J., Dransfield I., Gregory C., Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2002, 2:965-975.
69. Sawabe M. Vascular aging: from molecular mechanism to clinical significance. Geriatr. Gerontol. Int. 2010, 10(Suppl. 1):S213-S220.
70. Schaub F.J., Han D.K., Liles W.C., Adams L.D., Coats S.A., Ramachandran R.K., Seifert R.A., Schwartz S.M., Bowen-Pope D.F. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat. Med. 2000, 6:790-796.
71. Schaub F.J., Liles W.C., Ferri N., Sayson K., Seifert R.A., Bowen-Pope D.F. Fas and Fas-associated death domain protein regulate monocyte chemoattractant protein-1 expression by human smooth muscle cells through caspase- and calpain-dependent release of interleukin-1alpha. Circ. Res. 2003, 93:515-522.
72. Schrijvers D.M., De Meyer G.R., Kockx M.M., Herman A.G., Martinet W. Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1256-1261.
73. Slomp J., Gittenberger De Groot A.C., Glukhova M.A., Van Munsteren J.C., Kockx M.M., Schwartz S.M., Koteliansky V.E. Differentiation, dedifferentiation, and apoptosis of smooth muscle cells during the development of the human ductus arteriosus. Arterioscler. Thromb. Vasc. Biol. 1997, 17:1003-1009.
74. Stoneman V.E., Bennett M.R. Role of Fas/Fas-L in vascular cell apoptosis. J. Cardiovasc. Pharmacol. 2009, 53:100-108.
75. Tabas I., Tall A., Accili D. The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression. Circ. Res. 2009, 106:58-67.
76. Tanaka N., Abe-Dohmae S., Iwamoto N., Fitzgerald M.L., Yokoyama S. HMG-CoA reductase inhibitors enhance phagocytosis by upregulating ATP-binding cassette transporter A7. Atherosclerosis 2011, 217:407-414.
77. -/- mice. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1421-1428.
78. -/- mice lacking macrophage Bcl-2. Arterioscler. Thromb. Vasc. Biol. 2009, 29:169-172.
79. Tzima E., Irani-Tehrani M., Kiosses W.B., Dejana E., Schultz D.A., Engelhardt B., Cao G., Delisser H., Schwartz M.A. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 2005, 437:426-431.
80. Voll R., Herrmann M., Roth E., Stach C., Kalden J. Immunosuppressive effects of apoptotic cells. Nature 1997, 390:350-351.
81. Walpola P.L., Gotlieb A.I., Langille B.L. Monocyte adhesion and changes in endothelial cell number, morphology, and F-actin distribution elicited by low shear stress in vivo. Am. J. Pathol. 1993, 142:1392-1400.
82. Wang Z., Liu B., Wang P., Dong X., Fernandez-Hernando C., Li Z., Hla T., Li Z., Claffey K., Smith J.D., Wu D. Phospholipase C beta3 deficiency leads to macrophage hypersensitivity to apoptotic induction and reduction of atherosclerosis in mice. J. Clin. Invest. 2008, 118:195-204.
83. Yu H., Stoneman V., Clarke M., Figg N., Xin H.B., Kotlikoff M., Littlewood T., Bennett M. Bone marrow-derived smooth muscle-like cells are infrequent in advanced primary atherosclerotic plaques but promote atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2011, 31:1291-1299.
84. Yu H., Clarke M., Figg N., Littlewood T., Bennett M. Smooth muscle cell apoptosis promotes vessel remodeling and repair, via activation of cell migration, proliferation and collagen synthesis. ATVB 2011, 31:2402-2409.
85. Zernecke A., Schober A., Bot I., Von Hundelshausen P., Liehn E.A., Mopps B., Mericskay M., Gierschik P., Biessen E.A., Weber C. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ. Res. 2005, 96:784-791.